Cargando…

Therapeutic Mechanism of Lapatinib Combined with Sulforaphane on Gastric Cancer

BACKGROUND: Lapatinib is a small-molecule tyrosine kinase inhibitor that plays important roles in cell proliferation and survival. Administration of lapatinib with capecitabine is an effective treatment for HER2-positive metastatic BC. However, the effects of lapatinib on gastric cancer (GC) remain...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yi, Huixing, Li, Zheming, Liu, Xiaoxi, Dai, Shijie, Li, Shouye
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476239/ https://www.ncbi.nlm.nih.gov/pubmed/34589134 http://dx.doi.org/10.1155/2021/9933274

Ejemplares similares

Combining lapatinib and pertuzumab to overcome lapatinib resistance due to NRG1-mediated signalling in HER2-amplified breast cancer
por: Leung, Wing-yin, et al.
Publicado: (2015)

Lapatinib: the evidence for its therapeutic value in metastatic breast cancer
por: Thomson, Andrew
Publicado: (2005)

Inhibition of Hes1 enhances lapatinib sensitivity in gastric cancer sphere-forming cells
por: Li, Luchun, et al.
Publicado: (2017)

The molecular mechanism of action of aspirin, curcumin and sulforaphane combinations in the chemoprevention of pancreatic cancer
por: THAKKAR, ARVIND, et al.
Publicado: (2013)

The neuroprotective mechanisms and effects of sulforaphane
por: Klomparens, Eric A, et al.
Publicado: (2019)

Lapatinib-loaded human serum albumin nanoparticles for the prevention and treatment of triple-negative breast cancer metastasis to the brain
por: Wan, Xu, et al.
Publicado: (2016)

Lapatinib and lapatinib plus trastuzumab therapy versus trastuzumab therapy for HER2 positive breast cancer patients: an updated systematic review and meta-analysis
por: Yuan, Ye, et al.
Publicado: (2022)

Artesunate Alleviates Hyperoxia-Induced Lung Injury in Neonatal Mice by Inhibiting NLRP3 Inflammasome Activation
por: Xie, Bin, et al.
Publicado: (2023)

Anticancer Effect of Fucoidan in Combination with Tyrosine Kinase Inhibitor Lapatinib
por: Oh, Byeongsang, et al.
Publicado: (2014)

A novel treatment strategy for lapatinib resistance in a subset of HER2-amplified gastric cancer
por: Ning, Gang, et al.
Publicado: (2021)

Biological mechanisms and clinical efficacy of sulforaphane for mental disorders
por: Zheng, Wensi, et al.
Publicado: (2022)

Immunomodulatory and Antitumor Effects of a Novel TLR7 Agonist Combined with Lapatinib
por: Gao, Ningning, et al.
Publicado: (2016)

Novel nanosystem to enhance the antitumor activity of lapatinib in breast cancer treatment: Therapeutic efficacy evaluation
por: Huo, Zhi-Jun, et al.
Publicado: (2015)

Therapeutic potential of sulforaphane in liver diseases: a review
por: Yan, Liang, et al.
Publicado: (2023)

Sulforaphane for the chemoprevention of bladder cancer: molecular mechanism targeted approach
por: Leone, Andrew, et al.
Publicado: (2017)

Exosomes Derived from Nerve Stem Cells Loaded with FTY720 Promote the Recovery after Spinal Cord Injury in Rats by PTEN/AKT Signal Pathway
por: Chen, Jianbin, et al.
Publicado: (2021)

Screening and Identification of Key Biomarkers in Acquired Lapatinib-Resistant Breast Cancer
por: Bao, Shengnan, et al.
Publicado: (2020)

Molecular effects of Lapatinib in the treatment of HER2 overexpressing oesophago-gastric adenocarcinoma
por: De Silva, Nadeera, et al.
Publicado: (2015)

Sulforaphane salads
por: Tiwari, Ashok Kumar
Publicado: (2018)

Efficacy and Tolerability of Lapatinib in the Management of Breast Cancer
por: Rana, Punam, et al.
Publicado: (2012)

Targeted treatment of advanced and metastaticbreast cancer with lapatinib
por: Corkery, Brendan, et al.
Publicado: (2008)

Structural investigations on mechanism of lapatinib resistance caused by HER-2 mutants
por: Verma, Sharad, et al.
Publicado: (2018)

HSP90 Inhibitor, 17-DMAG, Alone and in Combination with Lapatinib Attenuates Acquired Lapatinib-Resistance in ER-positive, HER2-Overexpressing Breast Cancer Cell Line
por: Lee, Hye Jin, et al.
Publicado: (2020)

Synergistic Activity of the HSP90 Inhibitor Ganetespib With Lapatinib Reverses Acquired Lapatinib Resistance in HER2-Positive Breast Cancer Cells
por: Ye, Min, et al.
Publicado: (2021)

Q-TWiST analysis of lapatinib combined with capecitabine for the treatment of metastatic breast cancer
por: Sherrill, B, et al.
Publicado: (2008)

Phase I and pharmacological trial of lapatinib in combination with gemcitabine in patients with advanced breast cancer
por: van der Noll, R., et al.
Publicado: (2015)

Chemopreventive activity of sulforaphane
por: Jiang, Xin, et al.
Publicado: (2018)

A randomized phase II study of lapatinib + pazopanib versus lapatinib in patients with HER2+ inflammatory breast cancer
por: Cristofanilli, Massimo, et al.
Publicado: (2012)

Liposomal Lapatinib in Combination with Low-Dose Photodynamic Therapy for the Treatment of Glioma
por: Fisher, Carl, et al.
Publicado: (2019)

Real‐world data of lapatinib and treatment after lapatinib in patients with previously treated HER2‐positive metastatic breast cancer: A multicenter, retrospective study
por: Xie, Yizhao, et al.
Publicado: (2020)

Fructus mume Extracts Alleviate Diarrhea in Breast Cancer Patients Receiving the Combination Therapy of Lapatinib and Capecitabine
por: Xing, Hua, et al.
Publicado: (2018)

Factors Influencing Sulforaphane Content in Broccoli Sprouts and Subsequent Sulforaphane Extraction
por: Tříska, Jan, et al.
Publicado: (2021)

Effects of lapatinib on cell proliferation and apoptosis in NB4 cells
por: Liu, Lu, et al.
Publicado: (2018)

Activation of Human Salivary Aldehyde Dehydrogenase by Sulforaphane: Mechanism and Significance
por: Alam, Md. Fazle, et al.
Publicado: (2016)

Heparanase mediates a novel mechanism in lapatinib-resistant brain metastatic breast cancer()()
por: Zhang, Lixin, et al.
Publicado: (2015)

Lapatinib promotes the incidence of hepatotoxicity by increasing chemotherapeutic agent accumulation in hepatocytes
por: Dai, ChunLing, et al.
Publicado: (2015)

Lapatinib for the treatment of breast cancer in the People’s Republic of China
por: Wang, Hongjiang
Publicado: (2014)

Development of prediction tools for diarrhea and rash in breast cancer patients receiving lapatinib in combination with capecitabine
por: Dranitsaris, George, et al.
Publicado: (2014)

Sulforaphane induces S-phase arrest and apoptosis via p53-dependent manner in gastric cancer cells
por: Wang, Yuan, et al.
Publicado: (2021)

Interaction of Sulforaphane with DNA and RNA
por: Abassi Joozdani, Farzaneh, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_pa7pucropkgv2djpdn3glmh908